estropipate
(HZEQBCVBILBTEP-ZFINNJDLSA-N)
Structure
- SMILES
- N1CCNCC1.O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O
- Molecular Formula:
- C22H32N2O5S
- Molecular Weight:
- 436.565
- Log P:
- 4.2110
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 3
- TPSA:
- 113.11
- CAS Number(s):
- 7280-37-7
Synonym(s)
1.
estropipate
2.
Genoral
3.
Harmogen
4.
Harmonet
5.
Ogen
6.
Ortho-Est
7.
piperazine estrone sulfate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 6 | US FAERS | |
| 2 | Arthralgia | FAERS: 2 | US FAERS | |
| 3 | Breast Cyst | FAERS: 2 | US FAERS | |
| 4 | Dizziness | FAERS: 2 | US FAERS | |
| 5 | Headache | FAERS: 2 | US FAERS | |
| 6 | Hypersensitivity | FAERS: 2 | US FAERS | |
| 7 | Pharmaceutical product complaint | FAERS: 2 | US FAERS | |
| 8 | Product substitution issue | FAERS: 2 | US FAERS | |
| 9 | Sarcoidosis | FAERS: 2 | US FAERS | |
| 10 | Shock | FAERS: 2 | US FAERS | |
| 11 | Tremor | FAERS: 2 | US FAERS | |
| 12 | nervous system disorder | FAERS: 2 | US FAERS | |
| 13 | Ageusia | FAERS: 1 | US FAERS | |
| 14 | Alopecia | FAERS: 1 | US FAERS | |
| 15 | Carcinoma in situ of skin | FAERS: 1 | US FAERS | |
| 16 | Drug administration error | FAERS: 1 | US FAERS | |
| 17 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 18 | Emotional distress | FAERS: 1 | US FAERS | |
| 19 | Erythema | FAERS: 1 | US FAERS | |
| 20 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 21 | Hormone level abnormal | FAERS: 1 | US FAERS | |
| 22 | Inadequate analgesia | FAERS: 1 | US FAERS | |
| 23 | Malaise | FAERS: 1 | US FAERS | |
| 24 | Mood swings | FAERS: 1 | US FAERS | |
| 25 | Night sweats | FAERS: 1 | US FAERS | |
| 26 | Pain | FAERS: 1 | US FAERS | |
| 27 | Pregnancy on oral contraceptive | FAERS: 1 | US FAERS | |
| 28 | Pruritus | FAERS: 1 | US FAERS | |
| 29 | Swelling | FAERS: 1 | US FAERS | |
| 30 | Therapeutic response unexpected with drug substitution | FAERS: 1 | US FAERS | |
| 31 | Therapy change | FAERS: 1 | US FAERS | |
| 32 | Urticaria | FAERS: 1 | US FAERS | |
| 33 | Visual Impairment | FAERS: 1 | US FAERS | |
| 34 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 35 | Wrong technique in product usage process | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.